{"entity":{"type":"insider","cik":"0001423898","url":"/insider/0001423898","json_url":"/insider/0001423898.json","name":"Taub Rebecca","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":93,"n_filings":15,"first":"2008-12-19","last":"2026-03-06","span_basis":"filed_date"},"name_variants":[{"name":"Taub Rebecca","source":"filing","n_filings":15,"first_seen":"2008-12-19","last_seen":"2026-03-06"}],"transactions":[{"id":6173023,"accession":"0001628280-26-015736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-015736","line_url":"/filing/0001628280-26-015736#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":491.0,"shares_display":"491","price_per_share":431.94,"price_display":"431.94","price_state":"stated","total_value":212082.54,"total_display":"212,082.54","total_whole":"212,083","shares_owned_after":452213.0,"shares_owned_after_display":"452,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-06","scope":"insider"},{"id":5933388,"accession":"0001628280-26-003452","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-003452","line_url":"/filing/0001628280-26-003452#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":647.0,"shares_display":"647","price_per_share":492.42,"price_display":"492.42","price_state":"stated","total_value":318595.74,"total_display":"318,595.74","total_whole":"318,596","shares_owned_after":452704.0,"shares_owned_after_display":"452,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-26","filed_date":"2026-01-26","scope":"insider"},{"id":5786977,"accession":"0001628280-26-002735","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-002735","line_url":"/filing/0001628280-26-002735#line-1","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2238.0,"shares_display":"2,238","price_per_share":490.77,"price_display":"490.77","price_state":"stated","total_value":1098343.26,"total_display":"1,098,343.26","total_whole":"1,098,343","shares_owned_after":453351.0,"shares_owned_after_display":"453,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-20","scope":"insider"},{"id":5845558,"accession":"0001628280-26-001970","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-001970","line_url":"/filing/0001628280-26-001970","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240.0,"shares_display":"240","price_per_share":550.3333333333334,"price_display":"550.33","price_state":"stated","total_value":132080.0,"total_display":"132,080.00","total_whole":"132,080","shares_owned_after":455589.0,"shares_owned_after_display":"455,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-13","scope":"insider","n_lines":2},{"id":5756987,"accession":"0001628280-26-001961","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001628280-26-001961","line_url":"/filing/0001628280-26-001961","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18410.0,"shares_display":"18,410","price_per_share":522.3960936067355,"price_display":"522.40","price_state":"stated","total_value":9617312.0833,"total_display":"9,617,312.08","total_whole":"9,617,312","shares_owned_after":466999.0,"shares_owned_after_display":"466,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-09","filed_date":"2026-01-13","scope":"insider","n_lines":28},{"id":4742420,"accession":"0001628280-25-056792","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001628280-25-056792","line_url":"/filing/0001628280-25-056792","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18650.0,"shares_display":"18,650","price_per_share":552.1486811206435,"price_display":"552.15","price_state":"stated","total_value":10297572.9029,"total_display":"10,297,572.90","total_whole":"10,297,573","shares_owned_after":473625.0,"shares_owned_after_display":"473,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-12","scope":"insider","n_lines":9},{"id":4590396,"accession":"0001423898-25-000005","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001423898-25-000005","line_url":"/filing/0001423898-25-000005#line-14","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6715.0,"shares_display":"6,715","price_per_share":357.8528,"price_display":"357.85","price_state":"stated","total_value":2402981.552,"total_display":"2,402,981.55","total_whole":"2,402,982","shares_owned_after":468285.0,"shares_owned_after_display":"468,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4590393,"accession":"0001423898-25-000005","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001423898-25-000005","line_url":"/filing/0001423898-25-000005#line-13","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6541.0,"shares_display":"6,541","price_per_share":358.811,"price_display":"358.81","price_state":"stated","total_value":2346982.751,"total_display":"2,346,982.75","total_whole":"2,346,983","shares_owned_after":461744.0,"shares_owned_after_display":"461,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4590389,"accession":"0001423898-25-000005","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001423898-25-000005","line_url":"/filing/0001423898-25-000005#line-12","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6479.0,"shares_display":"6,479","price_per_share":354.9735,"price_display":"354.97","price_state":"stated","total_value":2299873.3065,"total_display":"2,299,873.31","total_whole":"2,299,873","shares_owned_after":485616.0,"shares_owned_after_display":"485,616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4590385,"accession":"0001423898-25-000005","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001423898-25-000005","line_url":"/filing/0001423898-25-000005#line-11","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5752.0,"shares_display":"5,752","price_per_share":355.9521,"price_display":"355.95","price_state":"stated","total_value":2047436.4792,"total_display":"2,047,436.48","total_whole":"2,047,436","shares_owned_after":479864.0,"shares_owned_after_display":"479,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4590382,"accession":"0001423898-25-000005","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001423898-25-000005","line_url":"/filing/0001423898-25-000005#line-10","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4864.0,"shares_display":"4,864","price_per_share":356.8794,"price_display":"356.88","price_state":"stated","total_value":1735861.4016,"total_display":"1,735,861.40","total_whole":"1,735,861","shares_owned_after":475000.0,"shares_owned_after_display":"475,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4590379,"accession":"0001423898-25-000005","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001423898-25-000005","line_url":"/filing/0001423898-25-000005#line-9","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4587.0,"shares_display":"4,587","price_per_share":354.0434,"price_display":"354.04","price_state":"stated","total_value":1623997.0758,"total_display":"1,623,997.08","total_whole":"1,623,997","shares_owned_after":492095.0,"shares_owned_after_display":"492,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4590375,"accession":"0001423898-25-000005","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001423898-25-000005","line_url":"/filing/0001423898-25-000005#line-8","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3580.0,"shares_display":"3,580","price_per_share":350.8735,"price_display":"350.87","price_state":"stated","total_value":1256127.13,"total_display":"1,256,127.13","total_whole":"1,256,127","shares_owned_after":500727.0,"shares_owned_after_display":"500,727","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4590372,"accession":"0001423898-25-000005","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001423898-25-000005","line_url":"/filing/0001423898-25-000005#line-7","is_derivative":false,"issuer_cik":"0001157601","issuer_name":"MADRIGAL PHARMACEUTICALS, INC.","issuer_ticker":"MDGL","issuer_name_source":null,"issuer_url":"/issuer/0001157601","owner_cik":"0001423898","owner_name":"Taub Rebecca","owner_display_name":"Taub Rebecca","owner_url":"/insider/0001423898","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2870.0,"shares_display":"2,870","price_per_share":351.5996,"price_display":"351.60","price_state":"stated","total_value":1009090.852,"total_display":"1,009,090.85","total_whole":"1,009,091","shares_owned_after":497857.0,"shares_owned_after_display":"497,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"}],"collapsed":true,"next_cursor":"2025-08-12|4590372","ledger_fault":false,"count":{"value":93,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":92,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":93},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001157601","name":"MADRIGAL PHARMACEUTICALS, INC.","url":"/issuer/0001157601","role":"Director, Officer (Pres., R&D, and CMO)","n_filings":14,"first_seen":"2018-06-12","last_seen":"2026-03-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001003929","name":"VIA Pharmaceuticals, Inc.","url":"/issuer/0001003929","role":"Officer (SVP, Research & Development)","n_filings":1,"first_seen":"2008-12-19","last_seen":"2008-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001423898","retrieved_at":"2026-08-24T23:58:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}